Radiotherapy/Radiation / CR Cancer Research Results

Rad, Radiotherapy/Radiation: Click to Expand ⟱
Features:
Treatment of disease with radiation, especially by selective irradiation with x-rays or other ionizing radiation and by ingestion of radioisotopes.

Radiosensitizer
Atorvaqone, (mitochondria inhibitor) decrease O2 consumption making more O2 available as a radiosensitizer.
-Hypoxia (low oxygen levels) within tumors is a major cause of resistance to radiotherapy


CR, Complete Response: Click to Expand ⟱
Source:
Type:
Scientific Papers found: Click to Expand⟱
7627- HPT,  Rad,    Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
CR↑, OS↑, *toxicity↝, RadioS↑,
7621- HPT,  Rad,    Clinical effectiveness of combined whole body hyperthermia and external beam radiation therapy (EBRT) versus EBRT alone in patients with painful bony metastases: A phase III clinical trial study
- Trial, Pca, NA - Trial, BC, NA
Pain↓, Dose↝, CR↑,

Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0)

CR↑, 2,  

Drug Metabolism & Resistance(tgid=21)

Dose↝, 1,   RadioS↑, 1,  

Functional Outcomes(tgid=23)

OS↑, 1,   Pain↓, 1,  
Total Targets: 5

Pathway results for Effect on Normal Cells:


Functional Outcomes(tgid=23)

toxicity↝, 1,  
Total Targets: 1

Scientific Paper Hit Count for: CR, Complete Response
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:201  Target#:1672  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page